Brain Magnetic Susceptibility Changes in Patients with Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

REFERENCES

1. 1.↵
   2. Clifford DB,
   3. De Luca A,
   4. Simpson DM, et al

   . Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol 2010;9:438–46 doi:10.1016/S1474-4422(10)70028-4 pmid:20298967

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Dong-Si T,
   3. Richman S,
   4. Wattjes MP, et al

   . Outcome and survival of asymptomatic PML in natalizumab-treated MS patients. Ann Clin Transl Neurol 2014;1:755–64 doi:10.1002/acn3.114 pmid:25493267

   CrossRefPubMed
3. 3.↵
   2. Wattjes MP,
   3. Richert ND,
   4. Killestein J, et al

   . The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy. Mult Scler 2013;19:1826–40 doi:10.1177/1352458513510224 pmid:24192217

   Abstract/FREE Full Text
4. 4.↵
   2. Wattjes MP,
   3. Vennegoor A,
   4. Steenwijk MD, et al

   . MRI pattern in asymptomatic natalizumab-associated PML. J Neurol Neurosurg Psychiatry 2015;86:793–98 doi:10.1136/jnnp-2014-308630 pmid:25205744

   Abstract/FREE Full Text
5. 5.↵
   2. Yousry TA,
   3. Pelletier D,
   4. Cadavid D, et al

   . Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol 2012;72:779–87 doi:10.1002/ana.23676 pmid:23280794

   CrossRefPubMed
6. 6.↵
   2. Blair NF,
   3. Brew BJ,
   4. Halpern JP

   . Natalizumab-associated PML identified in the presymptomatic phase using MRI surveillance. Neurology 2012;78:507–08 doi:10.1212/WNL.0b013e318246d6d8 pmid:22302545

   FREE Full Text
7. 7.↵
   2. Bag AK,
   3. Curé JK,
   4. Chapman PR, et al

   . JC virus infection of the brain. AJNR Am J Neuroradiol 2010;31:1564–76 doi:10.3174/ajnr.A2035 pmid:20299430

   Abstract/FREE Full Text
8. 8.↵
   2. Wattjes MP,
   3. Verhoeff L,
   4. Zentjens W, et al

   . Punctate lesion pattern suggestive of perivascular inflammation in acute natalizumab-associated progressive multifocal leukoencephalopathy: productive JC virus infection or preclinical PML-IRIS manifestation? J Neurol Neurosurg Psychiatry 2013;84:1176–77 doi:10.1136/jnnp-2013-304986 pmid:23695498

   FREE Full Text
9. 9.↵
   2. Berger JR,
   3. Aksamit AJ,
   4. Clifford DB, et al

   . PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology 2013;80:1430–38 doi:10.1212/WNL.0b013e31828c2fa1 pmid:23568998

   Abstract/FREE Full Text
10. 10.↵
    2. Rudko DA,
    3. Solovey I,
    4. Gati JS, et al

    . Multiple sclerosis: improved identification of disease-relevant changes in gray and white matter by using susceptibility-based MR imaging. Radiology 2014;272:851–64 doi:10.1148/radiol.14132475 pmid:24828000

    CrossRefPubMed
11. 11.↵
    2. Major EO,
    3. Ault GS

    . Progressive multifocal leukoencephalopathy: clinical and laboratory observations on a viral induced demyelinating disease in the immunodeficient patient. Curr Opin Neurol 1995;8:184–90 doi:10.1097/00019052-199506000-00006 pmid:7551117

    CrossRefPubMedWeb of Science